Clinical Associate Professor
University of Illinois Chicago
Chicago, IL, United States
Dr. Burgos is a Clinical Associate Professor at the University of Illinois Chicago, where he holds appointments in the Infectious Diseases (ID) Sections within the Colleges of Pharmacy and Medicine. His practice interests in the outpatient setting include antiretroviral stewardship, management of opportunistic infections, and developing innovative ID services to improve the care of underserved populations. His research interests and expertise are in phase 3 clinical trials of HIV antiretrovirals, HCV treatment in substance use populations, and COVID-19 vaccines and treatments. As an educator, he coordinates and lectures in core, elective, and experiential ID courses. He was voted "Instructor of the Semester" for consecutive years for instilling a passion for ID topics in pharmacy students. He is also passionate about expanding opportunities to support ID pharmacists who work with underserved communities and identifying and expanding alternative career development and training paths in ID. Dr. Burgos is an appointed panel member in the Section Review Group and the Pharmacology Group for the NIH-CDC-HIVMA/IDSA Guidelines for Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV, where he provides ID pharmacist expertise and point of view.
Disclosure(s): Clinical Care Options: Honoraria (Terminated, December 31, 2023); Janssen Therapeutics & Vaccines: Grant/Research Support (Ongoing); Janssen Vaccines & Prevention B.V.: Grant/Research Support (Terminated, July 31, 2023); Merck & Co., Inc.: Grant/Research Support (Ongoing); OptumRx: Advisor/Consultant (Ongoing); Viiv Healthcare: Advisor/Consultant (Ongoing)
Friday, October 18, 2024
3:15 PM – 4:30 PM US PT
442 - Should We Ramp Up PrEP Initiation in Pharmacies? - Pro
Friday, October 18, 2024
3:51 PM – 4:09 PM US PT